Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to 0.87.

  • Praxis Precision Medicines' Equity Ratio fell 573.44% to 0.87 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.87, marking a year-over-year decrease of 573.44%. This contributed to the annual value of 0.92 for FY2024, which is 1639.63% up from last year.
  • According to the latest figures from Q3 2025, Praxis Precision Medicines' Equity Ratio is 0.87, which was down 573.44% from 0.89 recorded in Q2 2025.
  • Praxis Precision Medicines' 5-year Equity Ratio high stood at 0.95 for Q2 2024, and its period low was 0.66 during Q1 2023.
  • For the 4-year period, Praxis Precision Medicines' Equity Ratio averaged around 0.83, with its median value being 0.81 (2023).
  • As far as peak fluctuations go, Praxis Precision Medicines' Equity Ratio crashed by 1784.13% in 2023, and later soared by 3997.64% in 2024.
  • Over the past 4 years, Praxis Precision Medicines' Equity Ratio (Quarter) stood at 0.66 in 2022, then grew by 19.83% to 0.79 in 2023, then rose by 16.4% to 0.92 in 2024, then fell by 6.01% to 0.87 in 2025.
  • Its last three reported values are 0.87 in Q3 2025, 0.89 for Q2 2025, and 0.92 during Q1 2025.